Transplantation Updates

Transplantation - Highlighted Tweets

Data regarding antiviral immune responses in kidney transplant recipients (KTRs) to newer severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron lineages after 4 monovalent messenger RNA (mRNA) vaccine doses are limited. To address that, we conducted a prospective single-center observational cohort study of KTRs who had previously received 3 SARS-CoV-2 monovalent mRNA vaccines (mRNA-1273 or BNT162b2) and collected samples before and 1 mo after the fourth monovalent vaccine dose.

Among selected patients with type 2 diabetes mellitus (T2DM), simultaneous pancreas and kidney (SPK) transplants can be an effective option. However, data are limited about outcomes in T2DM SPK recipients based on the pretransplant C-peptide levels.

Transplantation Direct - Highlighted Tweet

We aimed to facilitate the donation of tissue samples for research by establishing a centralized system integrated in the organ donation program for collection, storage, and distribution of samples (the Australian Donation and Transplantation Biobank [ADTB]).

Urinary tract infections (UTIs) are prevalent in renal transplant (RTX) recipients and associated with worse outcomes. Early detection by sensitive diagnostic tests and appropriate treatment strategies in this cohort is therefore crucial, but evidence has shown that current methods may miss genuine infections. Research has shed light on the urinary tract microbial ecology of healthy individuals and nontransplant patients with UTI, but information on the RTx cohort is scant. We conducted a cross-sectional study to (i) compare the gold standard diagnostic culture with alternative techniques and (ii) characterize RTx patient urinary microbial communities.

Upcoming Webinar Presentation

Register Today for ITS 2023!

ITS 2023 begins April 30 -- Last chance to register!
Join us in Niagara-on-the-Lake and contribute to an exciting and stimulating scientific meeting that will inspire and challenge you!

IPITA-IXA-CTRMS 2023 Joint Congress

The Joint Congress organizers are pleased to announce that the abstract submission deadline has now been EXTENDED to May 4th at midnight ET.

Abstract Submission Information:
  • Submission deadline: May 4, 2023
  • Notification of acceptance: June 20, 2023
  • Registration: Presenters must be registered and have paid their registration fee by July 24, 2023; otherwise, the abstract will be removed from the program.
  • ONLY accepted abstracts by a presenter registered to attend the Congress will be published in an online supplement of the Transplantation Journal.
  • It is the submitter’s responsibility to ensure that all co-authors approve of the abstract’s submission, publication, and potential presentation.

In the News 



Staff Directory


The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6